Therapeutic effects of teriparatide on subchondral bone lesions and pain in mono-iodoacetate-induced osteoarthritis rat model
Objectives: Knee osteoarthritis (OA) represents a leading cause of chronic pain, with subchondral bone marrow lesions recognized as a critical contributor. Teriparatide (TPTD), a treatment for osteoporosis, promotes subchondral bone remodeling. However, its effects on subchondral bone lesions and as...
Saved in:
| Main Authors: | Koji Aso, Natsuki Sugimura, Masashi Izumi, Ikeuchi Masahiko |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Series: | Osteoarthritis and Cartilage Open |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2665913125000913 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE ROLE OF VASCULAR REMODELING IN THE FORMATION OF STRUCTURAL PHENOTYPES OF OSTEOARTHRITIS
by: M. A. KABALYK, et al.
Published: (2018-07-01) -
Multiple Myeloma Case Developed During the Use of the Teriparatide
by: Zehra Erdemir, et al.
Published: (2022-04-01) -
Fufang Duzhong Jiangu granule (FFDZ) ameliorates osteoarthritis development through maintaining subchondral bone homeostasis
by: Houfu Ling, et al.
Published: (2025-08-01) -
Osteochondral Alterations in Patients Treated with Total Knee Arthroplasty Due to Rheumatoid Arthritis and Primary Osteoarthritis: Cross-Sectional Study with Focus on Elucidating Effects of Knee Malalignment
by: Andreja Baljozovic, et al.
Published: (2025-05-01) -
Assessment of femur and tibia subchondral parts mineral bone density in gonarthrosis
by: E M Zaitseva, et al.
Published: (2005-02-01)